Latest News and Press Releases

AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on developing therapies for...

COLUMBUS, Ohio, May 07, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing...

-- On track to file IND and/or CTA for PM577 in Wilson Disease in H1 2026 and for PM647 in AATD mid-2026; initial clinical data from both programs expected in 2027 -- -- Continued regulatory dialogue...

- Data from Phase 1b/2 trial presented at ESMO Breast Cancer 2026 further validate a biomarker-driven development strategy for evorpacept - - Findings are consistent with previous results from the...

Zyter|TruCare modernizes TruCare on AWS to power AI-driven workflow execution, enabling scalable, reliable healthcare operations across 44M+ covered lives.

- Initiation of Phase 3 IMPACT DUCHENNE placebo-controlled, randomized, double-blind trial as part of Solid’s integrated, multi-trial development program designed to support registration and global...

SAN JOSE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, will release third quarter fiscal year 2026 earnings after the market closes on Tuesday,...

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- The 10th Capital Link Maritime Leaders Summit – Greece will take place on Monday, June 1, 2026, as an in-person event at the Athenaeum Intercontinental...

TORONTO, ON, May 07, 2026 (GLOBE NEWSWIRE) -- Canadian Council for Indigenous Business (CCIB), in collaboration with the Canadian Chamber of Commerce’s Business Data Lab (BDL), has launched the...

FDA accepted the new drug application (NDA) for ulixacaltamide in Essential Tremor with a PDUFA target action date of January 29, 2027, and the NDA for relutrigine, with priority review, in SCN2A and...